List view / Grid view
Production of protein therapeutics by mammalian cells is the most widely used bioprocess because of its ability to properly produce and fold a recombinant protein...
In this in-depth focus: Non-contact single cell adhesion and micromechanical property characterisation with ultrasound. Is high resolution mass spectrometry the missing piece in continuous bioproduction? Regulatory, clinical and logistics challenges of ATMPs in clinical research...
A report released has identified a two-tier manufacturing market and forecast increased acquisitions by Indian companies...
Important product additions to the BioPure range from Watson-Marlow Fluid Technology Group will reinforce the organisation’s position as the leading provider of technologies for complete high purity fluid path solutions...
Following FDA legislation in 1999, scrutinising packaging standards for extractables and leachables has become the norm. In this whitepaper, Eurofins examines the ways in which the evaluation of final packaging components is now carried out including the role of liquid and gas chromatography-mass spectrometry in the process.
21 April 2017 | By Ingenza
Edinburgh-based Ingenza is celebrating after being named the Innovator of the Year at the 2017 Made in Scotland awards, held at the Glasgow Science Centre on the 19th of April...
Commercial biomanufacturing dates to thousands of years and the first biological engine, the yeast, continues to be beneficial...
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
Pharmaceutical QbD: Omnipresence in the product development lifecycle; Expert View with Kaiser Optical Systems Inc.; and Reinventing commercial biomanufacturing...
In this application note, Kaiser Optical Systems, Inc. discuss raman-based nutrient control in bioprocessing...
31 May 2016 | By Eppendorf
Eppendorf's BioBLU 3f Single-Use Vessels specifically address the demands of high cell density fermentation of bacteria, yeasts and fungi...
3 July 2015 | By Payal Roychoudhury, PhD, formerly AstraZeneca
The past decade has been a period of unparalleled change and development in the fermentation industry. As the nature of this industry evolves, and in particular, with the increasing prominence of the new biopharmaceuticals (therapeutic proteins, diagnostic enzymes and monoclonal antibodies) the need for effective bioprocess monitoring grows in importance1.
